Tilaknagar Industries Ltd Board Approves Unaudited Financial Results for Q3 FY26

Tilaknagar Industries Ltd. announced that its Board of Directors approved the Unaudited Financial Results (Consolidated and Standalone) for the quarter and nine months ended December 31, 2025. The results were subject to a limited review by the Statutory Auditors. Key events during the period include the acquisition of Imperial Blue Business Division from Pernod Ricard India Private Limited, completed on December 1, 2025, and the issuance of Equity Shares and Warrants on a preferential basis.

Board Approval of Q3 FY26 Financial Results

The Board of Directors of Tilaknagar Industries Ltd. met on Friday, February 13, 2026, to consider and approve the Unaudited Financial Results for the quarter and nine months ending December 31, 2025. The results, presented on both a Consolidated and Standalone basis, were accompanied by the limited review reports from the Statutory Auditors, M/s. Harshil Shah & Company.

Financial Highlights (Consolidated)

For the quarter ended December 31, 2025, the Consolidated revenue from operations stood at ₹1,45,301.28 lacs, compared to ₹80,534.86 lacs in the corresponding quarter last year. Profit/(Loss) attributable to the owners of the Company for the quarter was a loss of ₹10,281.82 lacs. For the nine months ended December 31, 2025, revenue from operations reached ₹3,23,247.13 lacs, resulting in a loss attributable to owners of ₹10,540.84 lacs.

Key Operational and Corporate Events

Acquisition of Imperial Blue Business

A significant event during the quarter was the completion of the acquisition of the Imperial Blue business division from Pernod Ricard India Private Limited on December 01, 2025. This acquisition involved a lump-sum cash consideration of Rs. 3,442 crores, plus a deferred consideration of EUR 28 million. Acquisition-related costs of Rs. 169.42 crores were treated as ‘Exceptional Items’ in the financial results.

Preferential Issuance of Securities

During the quarter ended September 30, 2025, the company allotted 1,43,80,000 Equity Shares for cash at a price of Rs. 382/- per share, aggregating to Rs. 5,49,31,60,000/-. Furthermore, 4,57,15,000 Convertible Warrants were issued for cash at a price of Rs. 382/- per warrant, aggregating to Rs. 1,746,31,30,000/-. The company received an amount equivalent to Rs 15,43,75,75,000/- towards these warrants by December 31, 2025.

Regulatory Updates and Impairment Qualification

The Independent Auditors expressed a qualified conclusion on the results, primarily due to the management’s decision not to carry out an impairment assessment on one of the ENA plants, as indicated in Note 5 of the Consolidated Statement, a matter also qualified in the prior year’s audit report.

The notes also detail the ongoing legal matter concerning brand ownership in the Bombay High Court, where the company continues its uninterrupted and exclusive use of the disputed brand. Additionally, the financial results accounted for the impact of the New Labour Codes, effective from November 21, 2025, based on ascertainable information.

Source: BSE

Previous Article

Torrent Pharma Announces Q3 FY26 Results with 26% YoY Net Profit Growth and JB Chemicals Acquisition Integration

Next Article

Crisil Limited Board Approves FY2025 Financial Results, Recommends Final Dividend, and Approves Key Re-appointments